Navigation Links
Sequenom to Present at Two Financial Conferences in March
Date:3/3/2010

SAN DIEGO, March 3 /PRNewswire-FirstCall/ -- Sequenom, Inc. (Nasdaq: SQNM) today announced that Harry F. Hixson, PhD, chairman and interim CEO, will present an overview of the company at the following conferences in March.

  • ROTH 22nd Annual OC Growth Stock Conference
  • Location: The Ritz Carlton, Dana Point, CA
  • Presentation Date: Wednesday March 17, 2010
  • Presentation time: 9:00am P.T.

  • Barclays Capital 2010 Global Healthcare Conference
  • Location: Loews Miami Hotel, Miami, FL
  • Presentation date: Wednesday, March 24, 2010
  • Presentation time: 2:00pm E.T.

A live webcast and 30-day archive of these presentations will be available at http://ir.sequenom.com.

About Sequenom

Sequenom, Inc. (NASDAQ: SQNM) is a life sciences company committed to improving healthcare through revolutionary genetic analysis solutions. Sequenom develops innovative technology, products and diagnostic tests that target and serve discovery and clinical research, and molecular diagnostics markets. The company was founded in 1994 and is headquartered in San Diego, California. Sequenom maintains a Web site at http://www.sequenom.com to which Sequenom regularly posts copies of its press releases as well as additional information about Sequenom. Interested persons can subscribe on the Sequenom Web site to email alerts or RSS feeds that are sent automatically when Sequenom issues press releases, files its reports with the Securities and Exchange Commission or posts certain other information to the Web site.

(Logo:  http://www.newscom.com/cgi-bin/prnh/20040415/SQNMLOGO)

SOURCE Sequenom, Inc.

Back to top

RELATED LINKS
http://www.sequenom.com

'/>"/>

SOURCE Sequenom, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Sequenom Appoints Two New Board Members
2. SEQUENOM Announces Partnership With GeneWorks for Sales & Marketing of MassARRAY Systems and Applications in Australia
3. SEQUENOM Reports Second Quarter 2009 Financial Results and Highlights
4. SEQUENOM Announces Launch of MassARRAY Compact 96 System
5. SEQUENOM to Hold First Quarter 2009 Financial Results Conference Call on April 30
6. Webcast Alert: Sequenom: Defining the Future of Noninvasive Prenatal Diagnostics
7. Sequenom to Webcast Analyst and Investor Briefing Presentation on June 3
8. Sequenom to Webcast Analyst and Investor Briefing Presentation on September 24
9. Sangamo BioSciences Announces Presentation at Cowen and Company Health Care Conference
10. Tianyin Pharmaceutical Co., Inc. to Present at the 2010 Rodman & Renshaw Annual China Investment Conference in Beijing on March 9
11. VIVUS to Present at Two Upcoming Investor Conferences
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... October 12, 2017 , ... ... Rosalindâ„¢, the first-ever genomics analysis platform specifically designed for life science researchers ... honor of pioneering researcher Rosalind Franklin, who made a major contribution to ...
(Date:10/11/2017)... ... October 11, 2017 , ... The CRISPR-Cas9 ... enabling overexpression experiments and avoiding the use of exogenous expression plasmids. The simplicity ... for performing systematic gain-of-function studies. , This complement to loss-of-function studies, such ...
(Date:10/11/2017)... Alto, CA, USA (PRWEB) , ... October 11, 2017 , ... ... set to take place on 7th and 8th June 2018 in San Francisco, CA. ... policy influencers as well as several distinguished CEOs, board directors and government officials from ...
(Date:10/11/2017)... BioMarketing, a leading provider of patient support solutions, has announced ... network, which will launch this week. The VMS CNEs will ... to enhance the patient care experience by delivering peer-to-peer education ... professionals to help women who have been diagnosed and are ... ...
Breaking Biology Technology:
(Date:8/23/2017)... public,s help is being enlisted in what,s thought to be the biggest ... human body –and are believed to affect health.  ... The Microbiome Immunity Project is the largest study to date ... project's goal is to help advance scientific knowledge of the role of ... The ...
(Date:6/14/2017)... , June 15, 2017  IBM (NYSE: IBM ) ... international tech event dedicated to developing collaboration between startups and ... on June 15-17. During the event, nine startups will showcase ... value in various industries. France ... the international market, with a 30 percent increase in the ...
(Date:4/24/2017)... 24, 2017 Janice Kephart , ... Identity Strategy Partners, LLP (IdSP) , today issues ... President Trump,s March 6, 2017 Executive Order: ... vetting can be instilled with greater confidence, enabling ... all refugee applications are suspended by until at ...
Breaking Biology News(10 mins):